Audit report of Hangzhou Tianmushan Pharmaceutical Co., Ltd.

Related guarantees

The company serves as the guarantor:

Guarantee start Whether the guarantee has been guaranteed by the guaranteed party Guaranteed amount Guarantee expiration date

Hangzhou Tianmushan Pharmaceutical Co., Ltd. completed. Huangshan Tianmu Pharmaceutical Co., Ltd.

23,000,000.00 2024-3-27 2027-3-27 Fufen Co., Ltd.

Hangzhou Tianmushan Pharmaceutical Stock Huangshan Tianmu Mint Pharmaceutical

23,000,000.00 2024-3-28 2027-3-28 Fufen Co., Ltd.

1,927,800.00 2025-1-22 2026-1-22 No 3,260,200.00 2025-4-18 2026-4-18 No 4,366,000.00 2025-6-30 2026-6-30 No 9,234,000.00 2025-7-9 2026-7-9 No 10,000,800.00 2025-8-29 2026-8-29 No Hangzhou Tianmushan Pharmaceutical Stock Qingdao Tianmushan Health Science

3,030,000.00 2025-9-12 2026-9-12 Fufen Co., Ltd. Technology Co., Ltd.

3,900,000.00 2025-9-22 2026-9-22 No

585,000.00 2025-9-24 2026-9-24 No 3,168,500.00 2025-10-15 2026-10-15 No 15,900,000.00 2025-10-31 2026-10-30 No 14,100,000.00 2025-11-28 2026-10-30 No Huangshan Tianmu Pharmaceutical Co., Ltd. Hangzhou Tianmushan Pharmaceutical Co., Ltd. 3,160,000.00 2025-11-12 2026-11-11 No Limited company 7,055,000.00 2025-11-28 2025-11-27 No

Related party lending

Related parties Borrowing amount Start date Maturity date Description

dismantle

Yongxin Huarui Cultural Development Co., Ltd. 200,000.00 March 2022 Not agreed

Yongxin Huarui Cultural Development Co., Ltd. 14,851.00 January 2021 January 2022

Key management personnel compensation